Today: 28 February 2026
Subscribe
Browse Category

Stock Market Analysis 5 December 2025 - 14 February 2026

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

Stock Traders Daily on Dec. 29 issued a trading note on Enbridge Inc (ENB), citing a 15.2:1 risk-reward setup and detailing entry, target, and stop-loss levels for multiple strategies. The firm also flagged a “mid-channel oscillation” pattern. A Dec. 27 note set an 8.9:1 risk-reward profile for the Invesco MSCI EAFE Income Advantage ETF (EFAA), outlining specific price signals and targets.
29 December 2025
·
Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

Rare Metals Stocks Outlook: Silver’s Record Run, Lithium Demand Warning, and Rare Earth Supply Chains in Focus Before Monday’s Open

U.S. equity markets are closed Sunday after a volatile week for rare metals stocks. Silver hit a record $77.40/oz and platinum reached all-time highs, with U.S.-listed precious metal miners rising sharply. Tesla CEO Elon Musk warned high silver prices could hurt manufacturers. The S&P 500 ended Friday near records, with materials stocks leading gains.
28 December 2025
····
Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

Semiconductor Stocks Outlook: Memory Chip Shortage, AI Spending Debate, and What to Watch Before Monday’s Open

A global memory-chip shortage is driving up prices, with some segments more than doubling since February, Reuters reports. The PHLX Semiconductor Index closed Friday at 7,207.64 after a quiet session, as investors watch for updates on AI infrastructure and Big Tech spending. Nvidia shares rose after agreeing to license technology from Groq and hire its CEO. U.S. markets reopen Monday.
28 December 2025
·
Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

Natural Gas Prices Rise Again as Colder Forecasts Return — What Henry Hub, LNG Exports, Storage Data and Today’s Stock Market Mood Mean for Investors

Front-month NYMEX natural gas futures for January traded around $4.29/MMBtu Friday afternoon, up about 8.5% for the week as colder weather forecasts boosted demand expectations. Trading volumes remained thin after the holidays, amplifying price moves. Meteorologists projected lower temperatures through early January, lifting heating demand. U.S. natural gas production and demand both remain near record highs.
26 December 2025
···
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

The FDA cleared expanded indications for Intuitive Surgical’s da Vinci SP robotic system on December 10, 2025, adding inguinal hernia repair, cholecystectomy, and appendectomy. ISRG shares closed at $578 on December 24, with Q4 earnings expected in late January. Brian E. Miller will become Head of Digital and AI Strategy on January 1, 2026.
25 December 2025
·
Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

Applied Materials (AMAT) News and 2026 Outlook on Dec. 25, 2025: Record FY2025, China Export Curbs, Dividend, and Wall Street Forecasts

Applied Materials closed fiscal 2025 with record revenue of $28.37 billion, up 4% year over year, and annual GAAP EPS of $8.66. Shares last traded at $260.78 on Dec. 24 before U.S. markets shut for Christmas. Q4 revenue fell 3% to $6.80 billion, and the company guided Q1 FY2026 revenue to $6.85 billion plus or minus $0.5 billion. Investors are weighing export controls and new dividend news ahead of 2026.
25 December 2025
·
Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

Wells Fargo (WFC) News on Dec. 25, 2025: Options Clearing Expansion, Investment Banking Push, and 2026 Outlook After Asset Cap Lift

Wells Fargo expanded into options clearing in late December, moving further into a business dominated by major Wall Street firms. The bank also increased investment banking hires and signaled more job cuts for 2026. Its investment arm forecasts Fed rate cuts and higher equity targets next year. The moves follow the lifting of Wells Fargo’s growth cap earlier in 2025.
25 December 2025
·
Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

Adobe Stock Forecast: ADBE Holds Near $354 on Dec. 24, 2025 as AI Monetization, Semrush Deal, and Valuation Debate Intensify

Adobe closed the shortened Christmas Eve session at $354.13, with trading volume lighter than usual. Shares remain down about 20% for the year despite a recent rebound. Fiscal 2025 revenue reached $23.77 billion, with management highlighting AI-driven growth and issuing a 2026 outlook above Wall Street forecasts. U.S. markets closed at 1 p.m. ET, with broader equities near record highs.
24 December 2025
·
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

BioMarin Pharmaceutical agreed Friday to acquire Amicus Therapeutics for $14.50 per share in cash, valuing the company at $4.8 billion. FOLD shares closed near $14.18 after jumping 30% on the news. The deal is expected to close in Q2 2026, pending shareholder and regulatory approvals. Amicus disclosed a $175 million breakup fee and a June 19, 2026 outside date.
22 December 2025
····
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

BioMarin Pharmaceutical will acquire Amicus Therapeutics for $14.50 per share in cash, valuing the deal at about $4.8 billion. Amicus shares closed at $14.18 on December 19, reflecting a small merger spread tied to regulatory and deal-closing risks. Both boards approved the agreement. Closing is targeted for Q2 2026, pending shareholder and antitrust approvals.
20 December 2025
···
Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

Real Estate Stocks Outlook for 2026: REITs, Homebuilders, and PropTech Reset After December Rate Cuts

The Federal Reserve cut its policy rate to 3.5%–3.75% in December, but 30-year mortgage rates remain near 6.21%, according to Freddie Mac. U.S. home prices are projected to rise just 1.4% in 2026, Reuters reports. Real estate stocks face mixed signals as high borrowing costs and affordability pressures persist. Google’s new home listing features are adding uncertainty for real estate tech firms.
20 December 2025
·
Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

Micron Earnings Preview: Surging Memory Chip Prices Put MU Stock in the Spotlight After Broadcom and Oracle’s AI Selloff

Micron Technology will report fiscal first-quarter results after the U.S. market closes on Dec. 17, 2025. Investors are watching for signs of sustained memory price gains, with DRAM and NAND prices rising sharply and average memory chip prices up 162% last quarter. The report comes amid volatility in AI-related stocks and growing scrutiny of AI infrastructure spending. Micron’s guidance is seen as a key indicator for semiconductor sentiment into 2026.
17 December 2025
·
Swiss Stock Market Week Ahead: SNB at 0%, UBS Capital-Rules Compromise, Tariff Relief, and the Key Catalysts to Watch (Dec 15–19, 2025)

Swiss Stock Market Week Ahead: SNB at 0%, UBS Capital-Rules Compromise, Tariff Relief, and the Key Catalysts to Watch (Dec 15–19, 2025)

Swiss equities extended losses last week, with the Swiss Market Index slipping to the high-12,800s amid late selling and profit-taking. The Swiss National Bank kept its policy rate at 0% and signaled readiness to intervene in currency markets. UBS shares hit their highest since 2008 after lawmakers floated a capital-reform compromise. U.S. tariffs on Swiss goods will drop to 15% from 39%, Swiss officials said.
13 December 2025
Tesla Stock (TSLA) in December 2025: Robotaxis, EV Slowdown and Price Targets to 2030

Tesla Stock (TSLA) in December 2025: Robotaxis, EV Slowdown and Price Targets to 2030

Tesla shares traded near $451 midday Thursday, valuing the company at $1.5 trillion. The stock is up 38% in six months but Wall Street’s average 12-month target sits below $400, according to StockAnalysis and 24/7 Wall St. Recent developments include Arizona’s approval for robotaxis and new FSD milestones. Morgan Stanley’s new analyst raised the price target to $425 but downgraded the stock.
11 December 2025
··
IREN Limited (IREN) Stock Forecast 2025: Can Microsoft’s $9.7B AI Cloud Deal Offset Massive Dilution Risk?

IREN Limited (IREN) Stock Forecast 2025: Can Microsoft’s $9.7B AI Cloud Deal Offset Massive Dilution Risk?

IREN Ltd shares closed at $44.24 on December 10, down 5.6% in 24 hours after a year of 205% gains, fueled by a $9.7 billion Microsoft AI cloud deal. The company, once a Bitcoin miner, now focuses on AI data centers and cloud services. IREN has raised $2.3 billion in convertible debt and equity, sparking debate over dilution. Market cap stands at $13.1 billion with a P/E of 24 and high volatility.
10 December 2025
···
Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics shares jumped 14% to $23.20 by mid-afternoon Monday after the company reported its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy met its primary endpoint. The stock touched an intraday high near $25.68 on volume over 2.5 million shares. Dyne plans to seek U.S. accelerated approval in 2026. The company reported $792 million in cash as of Q3 2025.
8 December 2025
·
Best Crypto US Stocks to Buy in December 2025: Top Miners, Exchanges and Bitcoin Treasury Plays

Best Crypto US Stocks to Buy in December 2025: Top Miners, Exchanges and Bitcoin Treasury Plays

Bitcoin fell over 30% from October highs above $126,000, trading near $85,000–$90,000 in December. US spot bitcoin ETFs saw a record $3.79 billion in outflows in November. Crypto-linked stocks dropped sharply, though some posted record revenues and expanded bitcoin holdings. Analysts at Coinbase and others say the decline resembles a mid-cycle reset, not a repeat of 2022.
7 December 2025
·········
Waaree Energies & Waaree Renewable Technologies in Focus: RSI Divergence, 288 MW US Order and ‘Hold’ Downgrade Shape the Story on 5 December 2025

Waaree Energies & Waaree Renewable Technologies in Focus: RSI Divergence, 288 MW US Order and ‘Hold’ Downgrade Shape the Story on 5 December 2025

Waaree Energies announced a 288 MW solar module order in the US on December 5, 2025. Waaree Renewable Technologies’ stock drew attention after analysts flagged a bullish RSI divergence and Simply Wall St argued the market is too pessimistic on its fundamentals. MarketsMojo downgraded Waaree Energies to “Hold” citing mixed signals. Google Trends showed a spike in searches for both companies.
5 December 2025
····
National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

NAB shares traded at A$40.64 on Friday, up 0.3–0.4%, after falling over 10% from a November peak near A$45.25. The stock offers a 4.2% fully franked dividend yield, backed by FY25 dividends of A$1.70 per share and a CET1 ratio of 11.7%. FY25 cash earnings were A$7.09 billion, flat year-on-year and slightly below expectations. NAB trades at 18–19 times trailing earnings, above sector averages.
5 December 2025
··
1 2
Go toTop